| Authors: |
Wermke M; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.; National Center for Tumor Diseases, Dresden, Germany., Araujo DM; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chatterjee M; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany., Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Holderried TAW; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reshef R; Columbia University Medical Center, New York, NY, USA., Bokemeyer C; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Alsdorf W; Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Wetzko K; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany., Brossart P; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany., Aslan K; Immatics Biotechnologies GmbH, Tübingen, Germany., Backert L; Immatics Biotechnologies GmbH, Tübingen, Germany., Bunk S; Immatics Biotechnologies GmbH, Tübingen, Germany., Fritsche J; Immatics Biotechnologies GmbH, Tübingen, Germany., Gulde S; Immatics Biotechnologies GmbH, Tübingen, Germany., Hengler S; Immatics Biotechnologies GmbH, Tübingen, Germany., Hilf N; Immatics Biotechnologies GmbH, Tübingen, Germany., Hossain MB; Immatics US, Inc., Houston, TX, USA., Hukelmann J; Immatics Biotechnologies GmbH, Tübingen, Germany., Kalra M; Immatics US, Inc., Houston, TX, USA., Krishna D; Immatics US, Inc., Houston, TX, USA., Kursunel MA; Immatics Biotechnologies GmbH, Tübingen, Germany., Maurer D; Immatics Biotechnologies GmbH, Tübingen, Germany., Mayer-Mokler A; Immatics Biotechnologies GmbH, Tübingen, Germany., Mendrzyk R; Immatics Biotechnologies GmbH, Tübingen, Germany., Mohamed A; Immatics US, Inc., Houston, TX, USA., Pozo K; Immatics US, Inc., Houston, TX, USA., Satelli A; Immatics US, Inc., Houston, TX, USA., Letizia M; Immatics Biotechnologies GmbH, Tübingen, Germany., Schuster H; Immatics Biotechnologies GmbH, Tübingen, Germany., Schoor O; Immatics Biotechnologies GmbH, Tübingen, Germany., Wagner C; Immatics Biotechnologies GmbH, Tübingen, Germany., Rammensee HG; Institute of Immunology, Eberhard Karls University Tübingen, Tübingen, Germany., Reinhardt C; Immatics Biotechnologies GmbH, Tübingen, Germany., Singh-Jasuja H; Immatics Biotechnologies GmbH, Tübingen, Germany., Walter S; Immatics US, Inc., Houston, TX, USA., Weinschenk T; Immatics Biotechnologies GmbH, Tübingen, Germany., Luke JJ; Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Britten CM; Immatics Biotechnologies GmbH, Tübingen, Germany. cedrik.britten@immatics.com. |
